Skip to main navigation Skip to search Skip to main content

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

  • for the ODYSSEY OUTCOMES Investigators

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology